Skip to content
DataLookout
Menu

STARSNCT03728478

STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS

StatusActive, Not Recruiting
PhasePhase 3
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 7 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date changed from estimate of Feb 28, 2025 to Oct 31, 2025 Show 6 more changesShow less
    • Eligibility criteria expanded, about 8 words
    • Trial status changed: Unknown → Active, Not Recruiting
    • Study completion pushed from Feb 28, 2025 to Dec 31, 2026
    • Secondary endpoints: details revised at 7 of 8 entries
    • Site details revised
    • Publications: details revised at 4 of 4 entries
  2. Minor Changed Registry marked status Unknown; last known: Recruiting
  3. Notable Primary and study completion dates: Feb 28, 2024 to Feb 28, 2025v7
  4. Notable Primary and study completion dates pushed to Feb 28, 2024
    • Study description expanded, about 121 words
    v6
  5. Notable Primary completion date: Mar 2021 to Mar 2022
    • Study completion date: Mar 2021 to Jun 2022
    v5
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 2019 to May 29, 2019
    v4
  2. Notable Start date: Dec 2018 to Mar 2019
    • Primary completion date: Dec 2020 to Mar 2021
    • Study completion date: Dec 2021 to Mar 2021
    v3
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Clinical remission on or off medication at 12 months
Timeframe: 12 months

Secondary (8)

Inactive disease
Time to inactive disease as per JADAS/JIA ACR criteria
Time to JADAS/JIA ACR clinical remission
Time spent in JADAS/JIA ACR inactive disease
Cumulative level of disease activity throughout the study period
Show 3 moreShow less
Time spent on therapy
Rate of flares
Rate of uveitis onset

Arms and interventions

Treatment arm 1: Step-upNo intervention

JIA patients managed with a Treat-To-Target strategy (T2T)

Treatment arm 2: Step-downExperimental

JIA patients treated with an early combined therapy

Drugs: Etanercept, Methotrexate, Intra-articular corticosteroid injections

Sites

1 site in 1 country

  • IRCCS Istituto Giannina GasliniGenova, GE, Italy